Partners and collaborators

HALo has established partnerships with numerous pharmaceutical companies (start-ups to multinationals), contract development and manufacturing organisations (CDMOs), formulation ingredient manufacturers, and some of the largest hospitals in the UK.

Future national healthcare provision will require long-acting medicines to overcome unmet clinical needs not addressable using conventional medicines, and create options for patients and clinicians to expand the choice available for healthcare provision.

HALo will address key technology questions, establish long-acting medicines awareness, and ensure patient involvement in future long-acting medicines development.

If you would like to work with us or have a related project you could benefit from our expertise on, please get in touch.

For more information, please contact HALo@liverpool.ac.uk.

Collaborations

Kidney-HALo Collaboration

A new collaboration between the The LifeArc-Kidney Research UK Centre for Rare Kidney Diseases and HALo aims to advance long-acting medicines for kidney disease.

Almost all kidney failure in children is caused by rare kidney diseases – but a disconnected translational pathway means new treatments don’t often reach those who need it. The LifeArc-KRUK Centre for Rare Kidney Diseases aims to bring transformational change to rare kidney disease research. Its ambitious goals include a clinical trial for a treatment that could cut kidney failure by a third, a new national biobank, and a collaboration to bring all affected children in the UK into the same research network. Initially focusing on childhood kidney diseases, the centre later hopes to connect with adult conditions and act as a model for other rare diseases. The collaboration with HALo will focus on long-acting medicines for kidney disease, aiming to provide revolutionary new options in care and treatment for those affected.

Partners

Achieving our ambition is a huge task and we cannot achieve this alone. We need partners to help co-create solutions with us. We have developed a Charter that sets out HALo’s plans and how Charter Partners can work with us to provide insights into the needs of local populations and their healthcare challenges, as well as collaborate in future research and innovation projects within the field of long-acting medicines.

If you would like to join HALo as a partner then we ask each organisation to sign up to the HALo Charter Partnership which you can find on this PDF link: celt-halo-charter-partnership

Contact the HALo team for more information.